De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Schizophrenia likely results from poorly understood genetic and environmental factors. We studied the gene encoding the synaptic protein SHANK3 in 285 controls and 185 schizophrenia patients with unaffected parents. Two de novo mutations (R1117X and R536W) were identified in two families, one being found in three affected brothers, suggesting germline mosaicism. Zebrafish and rat hippocampal neuron assays revealed behavior and differentiation defects resulting from the R1117X mutant. As mutations in SHANK3 were previously reported in autism, the occurrence of SHANK3 mutations in subjects with a schizophrenia phenotype suggests a molecular genetic link between these two neurodevelopmental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SHANK3 mutations have also been identified in individuals developing adult-onset SHANK3 related-disorders, such as schizophrenia and bipolar disorders 96,97”
From Progress toward treatments for synaptic defects in autism (2013) · cites this paper as [97]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Functional studies have confirmed that this mutation causes a loss of SHANK3 function in zebrafish and decreases neurite outgrowth in mice.50”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [50]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the case of schizophrenia, the de novo mutation R1117X with germline mosaicism has been observed in three affected brothers.”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [50]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, point mutations, including a nonsense mutation in exon 21 (p.R1117X) of SHANK3 have been reported in families with schizophrenia and mild intellectual disability (Gauthier et al., 2010).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Gauthier et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SHANK3 mutations have been identified in patients suffering from schizophrenia and bipolar disorder [45], [47].”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [47]
Experimental — accuracy not yet measured
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SIFT: predicting amino acid changes that affect protein function
Ng, P. C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg509 · Cited by 6,577 · cited 3×
“Bromberg Y, Rost B (2007) SNAP: Predict effect of non-synonymous polymorphisms on function.”
BackgroundAdaptive protein evolution at the Adh locus in Drosophila
McDonald, J. H., & Kreitman, M. (1991) · Nature · doi:10.1038/351652a0 · Cited by 3,283 · cited 2×
“To evaluate whether SHANK3 is accumulating deleterious mutations in human populations, we performed a standard population genetic test (14) which asks whether there is an excess of potentially disruptive amino acid mutations accumulating at this locus more so than expected by chance (Table S4).”
BackgroundHuman non-synonymous SNPs: server and survey
Ramensky, V. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf493 · Cited by 2,280
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Large recurrent microdeletions associated with schizophrenia.
GROUP, Stefansson, H., Rujescu, D., Cichon, S., Pietiläinen, O. P. H., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., et al. (2008) · Nature · doi:10.1038/nature07229 · Cited by 1,745 · cited 1×
“Interestingly, recent studies reported de novo copy-number variants in SCZ, providing further support for the de novo mutation hypothesis (5, 6).”
ResultDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602 · cited 3×
“Deleterious SHANK3 mutations have previously been reported in ASD (7, 8, 32), suggesting that the phenotypic spectrum of such mutations is rather broad.”
BackgroundAutism screening questionnaire: diagnostic validity
Berument, S. K., Rutter, M., Lord, C., Pickles, A., & Bailey, A. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.5.444 · Cited by 1,464 · cited 1×
“To exclude a possible diagnosis of autism, the Autism Screening Questionnaire (10) was completed and her score was 1 (score> 15= autism).”
BackgroundMapping autism risk loci using genetic linkage and chromosomal rearrangements
The Autism Genome Project Consortium (2007) · Nature Genetics · doi:10.1038/ng1985 · Cited by 1,402
Prediction of deleterious human alleles
Sunyaev, S. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.591 · Cited by 1,044
SNAP: predict effect of non-synonymous polymorphisms on function
Bromberg, Y., & Rost, B. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm238 · Cited by 863
Research works printed but not linked: 1
- Goslin K, Asmussen H, Banker G. Rat hippocampal neurons in low-density culture. In: Banker G, Goslin K, editors. Culturing Nerve Cells. Cambridge, MA: MIT Press; 1998. [Google Scholar]
Cited by
Items 201–300 of 371
Phospholipase Cβlb associates with a Shank3 complex at the cardiac sarcolemma
Grubb, D. R., Iliades, P., Cooley, N., Yu, Y. L., Luo, J., Filtz, T. M., & Woodcock, E. A. (2010) · The FASEB Journal · doi:10.1096/fj.10-171470 · Cited by 33
Imaging Approaches to Investigate Pathophysiological Mechanisms of Brain Disease in Zebrafish
Turrini, L., Roschi, L., de Vito, G., Pavone, F. S., & Vanzi, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129833 · Cited by 33
Subacute Neuropsychiatric Syndrome in Girls WithSHANK3Mutations Responds to Immunomodulation
Bey, A. L., Gorman, M., Gallentine, W. B., Kohlenberg, T. M., Frankovich, J., Jiang, Y., & van Haren, K. P. (2020) · PEDIATRICS · doi:10.1542/peds.2019-1490 · Cited by 29
Ali, F., Shao, L.-X., Gerhard, D. M., Sweasy, K., Pothula, S., Pittenger, C., Duman, R. S., & Kwan, A. C. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0708-6 · Cited by 26
“In particular, R1117X is a de novo nonsense mutation in SHANK3 in three affected brothers identified during a screen of schizophrenia patients [9].”
BackgroundInfluentialSHANK3 conformation regulates direct actin binding and crosstalk with Rap1 signaling
Salomaa, S. I., Miihkinen, M., Kremneva, E., Paatero, I., Lilja, J., Jacquemet, G., Vuorio, J., Antenucci, L., Kogan, K., Nia, F. H., et al. (2021) · Current Biology · doi:10.1016/j.cub.2021.09.022 · Cited by 31
The association of SHANK3 gene polymorphism and autism
Mashayekhi, F., Mizban, N., Bidabadi, E., & Salehi, Z. (2021) · Minerva Pediatrics · doi:10.23736/s2724-5276.16.04539-4 · Cited by 30
DNA methylation analysis in constitutional disorders: Clinical implications of the epigenome
Schenkel, L. C., Rodenhiser, D. I., Ainsworth, P., Paré, G., & Sadiković, B. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1113496 · Cited by 27
Structural basis for PDZ domain interactions in the post‐synaptic density scaffolding protein Shank3
Ponna, S. K., Ruskamo, S., Myllykoski, M., Keller, C., Boeckers, T. M., & Kursula, P. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14322 · Cited by 27
Chong, C. H., Li, Q., Mak, P. H. S., Ng, C. C. P., Leung, E. H. W., Tan, V. H., Chan, A. K. W., McAlonan, G. M., & Chan, S. Y. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0580-9 · Cited by 26
A recurrent SHANK3 frameshift variant in Autism Spectrum Disorder
Loureiro, L. O., Howe, J., Reuter, M. S., Iaboni, A., Calli, K., Roshandel, D., Pritišanac, I., Moses, A. M., Forman-Kay, J. D., Trost, B., et al. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00254-0 · Cited by 33
Self-citationAlternative polyadenylation and differential expression of Shank mRNAs in the synaptic neuropil
Epstein, I., Tushev, G., Will, T. J., Vlatkovic, I., Cajigas, I. J., & Schuman, E. M. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0137 · Cited by 28
Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment
Ziats, C. A., Grosvenor, L. P., Sarasua, S. M., Thurm, A. E., Swedo, S. E., Mahfouz, A. E., Rennert, O. M., & Ziats, M. N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213921 · Cited by 27
“SHANK3, located at the terminal end of the Phelan-McDermid region, has been repeatedly implicated in the pathogenesis of neurodevelopmental disorders such as autism and intellectual disability [13], as well as psychiatric diseases such as schizophrenia [14, 15] and bipolar disorder [16]; its protein product known to p…”
BackgroundGenetic analysis of the DLGAP1 gene as a candidate gene for schizophrenia
Li, J., Lu, C.-L., Cheng, M.-C., Luu, S.-U., Hsu, S.-H., & Chen, C. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.08.014 · Cited by 28
“In addition, multiple rare mutations in the SHANK3 gene that encodes a scaffolding protein abundant in the PSD of excitatory synapses on dendritic spines were found in patients with autism (Durand et al., 2007; Gauthier et al., 2009; Moessner et al., 2007) and schizophrenia (Gauthier et al., 2010).”
Fischer, I., Shohat, S., Leichtmann‐Bardoogo, Y., Nayak, R., Wiener, G., Rosh, I., Shemen, A., Tripathi, U., Rokach, M., Bar, E., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl4573 · Cited by 25
Novel Therapeutic Approach for Autism Spectrum Disorder: Focus on SHANK3
Uchino, S., & Waga, C. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666151029105547 · Cited by 30
Shank3B mutant mice display pitch discrimination enhancements and learning deficits
Rendall, A. R., Perrino, P. A., Buscarello, A. N., & FITCH, R. H. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2018.10.003 · Cited by 27
Altered nociceptive behavior and emotional contagion of pain in mouse models of autism
Martin, L. J., Poulson, S. J., Mannan, E., Sivaselvachandran, S., Cho, M., Setak, F., & Chan, C. (2021) · Genes Brain & Behavior · doi:10.1111/gbb.12778 · Cited by 26
Therapeutic approaches for shankopathies
Wang, X., Bey, A. L., Chung, L., Krystal, A. D., & Jiang, Y. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22084 · Cited by 27
“R1117X (Gauthier et al., 2010) and p.”
Anchoring high concentrations of SynGAP at postsynaptic densities via liquid-liquid phase separation
Zeng, M., Bai, G., & Zhang, M. (2017) · Small GTPases · doi:10.1080/21541248.2017.1320350 · Cited by 22
Poston, R. G., Dunn, C. J., Sarkar, P., & Saha, R. N. (2018) · Environmental Epigenetics · doi:10.1093/eep/dvx020 · Cited by 23
The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders
Alkelai, A., Greenbaum, L., Docherty, A. R., Shabalin, A. A., Povysil, G., Malakar, A., Hughes, D., Delaney, S. L., Peabody, E. P., McNamara, J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01383-9 · Cited by 27
de Bartolomeis, A., Vellucci, L., Simone, G. D., Mazza, B., Barone, A., & Ciccarelli, M. (2023) · Cells · doi:10.3390/cells12040574 · Cited by 23
“Furthermore, the intersection of Shank3 with the pathophysiology of schizophrenia has recently been marked by the discovery of several point mutations and small deletions of Shank3 [61], as well as the de novo R1117X mutation leading to loss of function of the Shank3 protein causally associated with schizophrenia [64].”
BackgroundThe NIH NeuroBioBank: creating opportunities for human brain research
Freund, M. P., Taylor, A. R., Ng, C., & Little, A. R. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63639-3.00004-9 · Cited by 26
Vitrac, A., Leblond, C. S., Rolland, T., Cliquet, F., Mathieu, A., Maruani, A., Delorme, R., Schön, M., Grabrucker, A. M., van Ravenswaaij‐Arts, C. M. A., et al. (2023) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2023.104732 · Cited by 24
Hippocampal Lnx1–NMDAR multiprotein complex mediates initial social memory
Liu, X.-D., Ai, P.-H., Zhu, X.-N., Pan, Y., Halford, M. M., Henkemeyer, M. J., Feng, D., Xu, T., Sun, S., & Xu, N. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0606-y · Cited by 22
English, J. A., Harauma, A., Föcking, M., Wynne, K. J., Scaife, C., Cagney, G., Moriguchi, T., & Cotter, D. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00208 · Cited by 21
de Bartolomeis, A., Avagliano, C., Vellucci, L., D’Ambrosio, L., Manchia, M., D’Urso, G., Buonaguro, E. F., & Iasevoli, F. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.08.019 · Cited by 19
Mutation Burden of Rare Variants in Schizophrenia Candidate Genes
Girard, S., Dion, P. A., Bourassa, C. V., Geoffroy, S., Lachance‐Touchette, P., Barhdadi, A., Langlois, M., Joober, R., Krebs, M., Dubé, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128988 · Cited by 23
“It is not surprising to find the SHANK3 gene as its implication in neurodevelopmental diseases has been shown many times[20,21].”
BackgroundSelf-citationWhere are the missing pieces of the schizophrenia genetics puzzle?
Girard, S., Xiong, L., Dion, P. A., & Rouleau, G. A. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.01.001 · Cited by 26
Self-citationFreudenberg, F., Marx, V., Mack, V., Layer, L. E., Klugmann, M., Seeburg, P. H., Sprengel, R., & Celikel, T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.12.003 · Cited by 21
“, 2007, 2012) or schizophrenia (Gauthier et al., 2010), suggesting a potential role for these genes in the development of mental disorders.”
Constitutional Epi/Genetic Conditions: Genetic, Epigenetic, and Environmental Factors
Schenkel, L. C., Rodenhiser, D. I., Siu, V. M., McCready, E., Ainsworth, P., & Sadiković, B. (2016) · Journal of Pediatric Genetics · doi:10.1055/s-0036-1593849 · Cited by 21
Pal, A., Goel, F., & Garg, V. K. (2025) · Neurogenetics · doi:10.1007/s10048-025-00828-5 · Cited by 20
Another piece of the autism puzzle
State, M. W. (2010) · Nature Genetics · doi:10.1038/ng0610-478 · Cited by 24
Jia, P., Chen, X., Fanous, A. H., & Zhao, Z. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0154-2 · Cited by 24
Effects of Psychotropic Drugs on Ribosomal Genes and Protein Synthesis
Liu, Z. S.-J., Truong, T. T. T., Bortolasci, C. C., Spolding, B., Panizzutti, B., Swinton, C., Kim, J. H., Kidnapillai, S., Richardson, M. F., Gray, L. J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137180 · Cited by 22
Tentative clinical diagnosis of Lujan‐Fryns syndrome—A conglomeration of different genetic entities?
Hackmann, K., Rump, A., Haas, S. A., Lemke, J. R., Fryns, J., Tzschach, A., Wieczorek, D., Albrecht, B., Kuechler, A., Ripperger, T., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37378 · Cited by 20
Autism Spectrum Disorder Genes: Disease-Related Networks and Compensatory Strategies
Lim, H. K., Yoon, J. H., & Song, M. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.922840 · Cited by 20
“SH3 and multiple ankyrin repeat domains 3 (SHANK3) deficiency in humans is associated with language and social communication problems of ASD, Phelan–McDermid syndrome, and schizophrenia (Durand et al., 2007; Gauthier et al., 2010).”
BackgroundKozol, R. A. (2018) · Journal of Developmental Biology · doi:10.3390/jdb6040029 · Cited by 20
Focus on Causality in ESC/iPSC-Based Modeling of Psychiatric Disorders
Hoffmann, A., Ziller, M. J., & Spengler, D. (2020) · Cells · doi:10.3390/cells9020366 · Cited by 19
“In support of this hypothesis, large-scale targeted resequencing and whole-exome sequencing identified SHANK3 point mutations and indels in subjects diagnosed ADHD, intellectual disability, and SCZ [67,68].”
BackgroundWan, L., Liu, D., Xiao, W., Zhang, B., Yan, X., Luo, Z., & Xiao, B. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01054-x · Cited by 23
Philippe, A., Craus, Y., Rio, M., Bahi‐Buisson, N., Boddaert, N., Malan, V., Bonnefont, J., & Robel, L. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0631-6 · Cited by 19
“Deletions and mutations in the SHANK3 gene have been repeatedly found when screening cohorts of patients assessed for autism spectrum disorder [1–3], for pervasive developmental disorder not otherwise specified (PDD-NOS) [4], for schizophrenia [5], for nonsyndromic intellectual disability [6] and for symptomatic conti…”
BackgroundSynapse-specific roles for microglia in development: New horizons in the prefrontal cortex
Blagburn-Blanco, S. V., Chappell, M. S., Biase, L. M. D., & DeNardo, L. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.965756 · Cited by 16
“While a large body of work has identified perturbations in neuronal genes and proteins that affect synaptic connectivity (Figures 2A,B; Gauthier et al., 2010; Marín, 2012; Nieto et al., 2013; Volk and Lewis, 2013; El-Ansary and Al-Ayadhi, 2014; McAllister, 2014; English et al., 2015; Estes and McAllister, 2015; Sincla…”
BackgroundOligonucleotide microarrays in constitutional genetic diagnosis
Keren, B., & Caignec, C. L. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.32 · Cited by 19
De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention
Gauthier, J., & Rouleau, G. A. (2012) · Genome Medicine · doi:10.1186/gm372 · Cited by 16
Self-citationShank is a dose-dependent regulator of Cav1 calcium current and CREB target expression
Pym, E. C. G., Sasidharan, N., Thompson-Peer, K. L., Simon, D. J., Anselmo, A. N., Sadreyev, R. I., Hall, Q., Nurrish, S., & Kaplan, J. M. (2017) · eLife · doi:10.7554/elife.18931 · Cited by 20
“Implications for understanding psychiatric disorders In humans, Shank deletions and duplications both confer risk for ASD and schizophrenia (Bonaglia et al., 2006; Durand et al., 2007; Failla et al., 2007; Gauthier et al., 2010; Han et al., 2013).”
BackgroundGenetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome
Dyar, B., Meaddough, E. L., Sarasua, S. M., Rogers, C. R., Phelan, K., & Boccuto, L. (2021) · Genes · doi:10.3390/genes12081192 · Cited by 15
“Since SHANK3 mutations have been associated with neuropsychiatric disorders more prevalent than PMS [56,57] it is fortunate that the role of pharmacogenetic considerations in treatment has been described in detail [58–60].”
BackgroundWhole exome sequencing reveals minimal differences between cell line and whole blood derived DNA
Schafer, C., Campbell, N. G., Cai, G., Yu, F., Makarov, V., Yoon, S. C., Daly, M. J., Gibbs, R. A., Schellenberg, G. D., Devlin, B., et al. (2013) · Genomics · doi:10.1016/j.ygeno.2013.05.005 · Cited by 15
Ponna, S. K., Myllykoski, M., Boeckers, T. M., & Kursula, P. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.121 · Cited by 14
“M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT Mutations and polymorphisms in Shanks, especially Shank2, have been linked to ASDs; in addition, a mutation in Shank3 was linked to schizophrenia [8].”
BackgroundAutism-associated gene shank3 is necessary for social contagion in zebrafish
Kareklas, K., Teles, M. C., Dreosti, E., & Oliveira, R. F. (2023) · Molecular Autism · doi:10.1186/s13229-023-00555-4 · Cited by 15
Mitz, A. R., Boccuto, L., & Thurm, A. E. (2024) · Clinical Genetics · doi:10.1111/cge.14503 · Cited by 16
Shen, X., Yeung, H. T., & Lai, K. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22644 · Cited by 16
Hu, T., Wu, C., Hsu, S.-H., Tsai, H.-Y., Cheng, F.-Y., & Cheng, M.-C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050783 · Cited by 13
Huang, C., Voglewede, M. M., Ozsen, E. N., Wang, H., & Zhang, H. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.07.024 · Cited by 17
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Gauthier, J., Hamdan, F. F., & Rouleau, G. A. (2011) · Journal of Visualized Experiments · doi:10.3791/2534 · Cited by 12
Self-citationA blueprint for research on Shankopathies: A view from research on autism spectrum disorder
Carbonetto, S. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22150 · Cited by 16
“…these different mutants and harken to human genetic studies where different mutations near SHANK3 were associated with distinct psychiatric disorders, such as schizophrenia vs. ASD (Gauthier et al., 2010), although behavior in the mouse models were similarly perturbed (Foldy et al., 2013).”
BackgroundInfluentialSelf-citationMatosin, N., Green, M. J., Andrews, J. L., Newell, K. A., & Fernandez, F. (2015) · Neuroreport · doi:10.1097/wnr.0000000000000491 · Cited by 13
“DLG4 (disks large homolog 4; encoding PSD95) genes [15–19].”
BackgroundAsta, L., Ricciardello, A., Cucinotta, F., Turriziani, L., Boncoddo, M., Bellomo, F., Angelini, J. M., Gnazzo, M., Scandolo, G., Pisanò, G., et al. (2024) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-024-09572-7 · Cited by 15
“SHANK3 deficiency has been linked to several psychiatric conditions [34, 35], including autism spectrum disorder (ASD) [36–41], bipolar disorder [42–44], and schizophrenia [45, 46].”
BackgroundScorrano, G., Francesco, L. D., Ludovico, A. D., Chiarelli, F., & Matricardi, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211982 · Cited by 15
Ni, P., Zhou, C., Liang, S., Jiang, Y., Liu, D., Shao, Z., Noh, H., Zhao, L., Yang, T., Zhang, C., et al. (2023) · Advanced Science · doi:10.1002/advs.202300455 · Cited by 15
Investigating the dark-side of the genome: a barrier to human disease variant discovery?
Ryan, N., & Corvin, A. P. (2023) · Biological Research · doi:10.1186/s40659-023-00455-0 · Cited by 11
A complex chromosomal rearrangement involving chromosomes 2, 5, and X in autism spectrum disorder
Griesi‐Oliveira, K., Moreira, D. D. P., Davis‐Wright, N., Sanders, S., Mason, C. E., Orabona, G. M., Vadasz, E., Bertola, D. R., State, M. W., & Passos‐Bueno, M. R. (2012) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32059 · Cited by 11
A 22q13.33 duplication harbouring the SHANK3 gene: does it cause neuropsychiatric disorders?
Johannessen, M., Haugen, I. B., Bakken, T. L., & Braaten, Ø. (2019) · BMJ Case Reports · doi:10.1136/bcr-2018-228258 · Cited by 14
Priol, A.-C., Denis, L., Boulanger, G., Thépaut, M., Geoffray, M., & Tordjman, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179464 · Cited by 13
“22q13 duplication SHANK 3 (Phelan-McDermid syndrome) [73,74] NA NA Normal to severe ID VEOS to AOS -ASD -ADHD Elongated head, high forehead, ptosis, long eyelashes, flat nose with a wide base, large ears”
nArgBP2-SAPAP-SHANK, the core postsynaptic triad associated with psychiatric disorders
Lee, S., Kim, J. A., & Chang, S. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-017-0018-5 · Cited by 20
Delling, J. P., Bauer, H. F., Gerlach-Arbeiter, S., Schön, M., Jacob, C., Wagner, J., Pedro, M. T., Knöll, B., & Boeckers, T. M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02559-9 · Cited by 10
Choudhary, A., Rosh, I., Hussein, Y., Netser, S., Shemen, A., Suliman, T., Rike, W. A., Simchi, L., Shklyar, B., Abu-Akel, A. M., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08474-x · Cited by 13
Zhu, W., Li, J., Chen, S., Zhang, J., Vetrini, F., Braxton, A. A., Eng, C. M., Yang, Y., Xia, F., Keller, K. L., et al. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38622 · Cited by 11
“SHANK3 mutations were also reported in patients with childhood-onset schizophrenia (Gauthier et al., 2010).”
BackgroundSelf-citationHu, T., Wang, Y.-C., Wu, C., Hsu, S.-H., Tsai, H.-Y., & Cheng, M.-C. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.524258 · Cited by 11
“Gauthier and colleagues identified a nonsense mutation of SHANK3 changing an arginine to a stop codon (SHANK3R1117X) in three brothers diagnosed with schizophrenia spectrum disorders (Gauthier et al., 2010).”
BackgroundShank promotes action potential repolarization by recruiting BK channels to calcium microdomains
Gao, L., Zhao, J., Ardiel, E., Hall, Q., Nurrish, S., & Kaplan, J. M. (2022) · eLife · doi:10.7554/elife.75140 · Cited by 12
“289 290 EGL-19 to SLO-2 coupling is sensitive to shn-1 gene dose 291 Deletion and duplication of human shank genes are both associated with ASD, 292 schizophrenia, and mania (Bonaglia et al., 2006; Durand et al., 2007; Failla et al., 2007; 293 Gauthier et al., 2010; Han et al., 2013).”
BackgroundInfluentialDevelopmental convergence and divergence in human stem cell models of autism spectrum disorderPreprint
Gordon, A., Yoon, S., Bicks, L. K., Martín, J. M., Pintacuda, G., Arteaga, S., Wamsley, B., Guo, Q., Elahi, L. S., Dolmetsch, R. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.01.587492 · Cited by 10
Nia, F. H., & Wittamer, V. (2025) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.16317 · Cited by 10
“42,46 Furthermore, disrupting disc1 , the ortholog of a schizophrenia risk gene involved in brain development and neurogenesis in a WNT signalling-dependent mechanism, caused the formation of a U-shaped body with truncated tail and early brain morphology abnormalities.”
VTA DA neuron excitatory synapses in Shank3 Δex4–9 mouse line
Bariselli, S., & Bellone, C. (2016) · Synapse · doi:10.1002/syn.21955 · Cited by 11
“Interestingly, duplication of the terminal segment containing the SHANK3 gene has been linked to developmental disorders (Durand et al., 2007), but also neuropsychiatric diseases such as bipolar disorders (Han et al., 2013) and schizophrenia (Gauthier et al., 2010).”
BackgroundWu, Z., Qin, J., You, Y., Ma, Y., Jia, M., Wang, L., Lu, T., Yue, W., Ruan, Y., Zhang, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02348-1 · Cited by 10
Persico, A. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397267-5.00045-5 · Cited by 9
The 1000 Genomes Project: deep genomic sequencing waiting for deep psychiatric phenotyping
Joober, R. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110026 · Cited by 10
“For example, mutations in SHANK3, a gene important for synaptic integrity, were reported in patients with autism(18) and schizophrenia.(19) Given the large number of rare mutations with potential impact on brain development, there is no doubt that this field of research will result in a plethora of case reports or sma…”
BackgroundSelf-citationBorba, J. V., Canzian, J., Resmim, C. M., da Silva, R. M., Duarte, M. C. F., Mohammed, K. A., Schoenau, W., Adedara, I. A., & Rosemberg, D. B. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105715 · Cited by 10
Lu, X., Ni, P., Suárez-Meade, P., Ma, Y., Forrest, E., Wang, G., Wang, Y., Quiñones‐Hinojosa, A., Gerstein, M., & Jiang, Y.-H. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114376 · Cited by 11
Chow, F. E., Gong, Y., & Lippa, C. F. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513518645 · Cited by 8
“3 deletion syndrome disrupts Shank3, resulting in PhelanMcDermid syndrome, an ASD.(9) Several additional duplications and deletions in Shank3 have been targeted in ASD,(8,9) suggesting the role of Shank in neurodevelopment.”
BackgroundInfluentialIshida, H., Skorobogatov, A., Yamniuk, A. P., & Vogel, H. J. (2018) · FEBS Letters · doi:10.1002/1873-3468.13209 · Cited by 8
Yang, Q., Liu, H., Li, Z., Wang, Y., & Liu, W. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.04.151 · Cited by 8
Bian, W.-J., Gonzalez, O. C., & de Lecea, L. (2023) · SLEEP · doi:10.1093/sleep/zsad131 · Cited by 9
Clustering of Ca V 1 .3 L‐type calcium channels by Shank3
Yang, Q., Perfitt, T. L., Quay, J., Hu, L., Lawson‐Qureshi, D., & Colbran, R. J. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15880 · Cited by 9
Dhossche, D. M., de Billy, C. D. C., Laurent‐Levinson, C., Normand, M. L., Recasens, C., Robel, L., & Philippe, A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1186555 · Cited by 9
“5% of individuals with schizophrenia (25, 26), supporting the significant clinical heterogeneity according to DSM-5.”
Sungur, A. Ö., Redecker, T. M., Andres, E., Dürichen, W., Schwarting, R. K. W., del Rey, A., & Wöhr, M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00419 · Cited by 9
“For instance, Fromer et al. (2014) reported a de novo SHANK1 frameshift mutation in a SCZ patient, and Lennertz et al. (2012) found that a SHANK1 promotor variant is associated with reduced auditory working memory capacity in SCZ patients.”
BackgroundInfluentialAxon guidance: semaphorin/neuropilin/plexin signaling
Verhagen, M. G., & Pasterkamp, R. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814407-7.00005-5 · Cited by 11
Cromosoma 22 en anillo en paciente con trastorno del neurodesarrollo
Mendoza, P., Huertas-Pérez, G., Rosales, L. M., & Rosado, L. A. M. (2023) · Salud Ciencia y Tecnología - Serie de Conferencias · doi:10.56294/sctconf2023345 · Cited by 7
Santarriaga, S., Gerlovin, K., Layadi, Y., & Karmacharya, R. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.02.029 · Cited by 7
Shiota, Y., Nishiyama, T., Yokoyama, S., Yoshimura, Y., Hasegawa, C., Tanaka, S., Iwasaki, S., & Kikuchi, M. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1352480 · Cited by 7
Structural and Functional Organization of the Postsynaptic Density
Verpelli, C., Heise, C., & Sala, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418675-0.00004-3 · Cited by 11
Clinical and Genetic Heterogeneity of Autism
Wang, Y., & Zhong, N. A. (2012) · InTech eBooks · doi:10.5772/48700 · Cited by 8
Rare Variants in Complex Traits: Novel Identification Strategies and the Role of de novo Mutations
Jouan, L., Gauthier, J., Dion, P. A., & Rouleau, G. A. (2012) · Human Heredity · doi:10.1159/000346478 · Cited by 8
Self-citationSHANK Mutations in Intellectual Disability and Autism Spectrum Disorder
Schmeißer, M. J., & Verpelli, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800109-7.00010-8 · Cited by 8
Feeling Fishy: Trait Differences in Zebrafish (Danio Rerio)
Khan, K. M., & Echevarria, D. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-59300-5_6 · Cited by 11
Hogstrom, L. J., Guo, S.-M., Murugadoss, K., & Bathe, M. (2015) · Interface Focus · doi:10.1098/rsfs.2015.0081 · Cited by 7
Autism and Schizophrenia: Genetic and Phenotypic Relationships
Vorstman, J. A. S., & Burbach, J. P. H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_96 · Cited by 8
Probing Synaptic Signaling with Optogenetic Stimulation and Genetically Encoded Calcium Reporters
Borja, G. B., Shroff, H., Upadhyay, H., Liu, P. W., Baru, V., Cheng, Y., McManus, O. B., Williams, L. A., Dempsey, G. T., & Werley, C. A. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0830-2_8 · Cited by 6
Zirn, B., Arning, L., Bartels, I., Shoukier, M., Hoffjan, S., Neubauer, B., & Hahn, A. (2012) · Neuropediatrics · doi:10.1055/s-0032-1307128 · Cited by 7
Motor patterns and swim path characteristics: the ethogram of zebrafish
Lakstygal, A. M., Demin, K. A., & Kalueff, A. V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817528-6.00008-5 · Cited by 6
Heck, D. H., & Lu, L. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.013 · Cited by 7
“(9) revealed that two de novo mutations in SHANK3 were assoiated with schizophrenia, suggesting that SHANK3 deficits repreent a common denominator at least for schizophrenia and autism.”
BackgroundStrategies to Advance Drug Discovery in Rare Monogenic Intellectual Disability Syndromes
Hettige, N. C., Manzano-Vargas, K., Jefri, M., & Ernst, C. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx090 · Cited by 5
Metadata
- Authors
- Gauthier, J., Champagne, N., Lafrenière, R. G., Xiong, L., Spiegelman, D., Brustein, E., Lapointe, M., Peng, H., Côté, M., Noreau, A., Hamdan, F. F., Addington, A. M., Rapoport, J. L., DeLisi, L. E., Krebs, M.-O., Joober, R., Fathalli, F., Mouaffak, F., Haghighi, A. P., Néri, C., Dubé, M.-P., Samuels, M. E., Marineau, C., Stone, E. A., Awadalla, P., Barker, P. A., Carbonetto, S., Drapeau, P., Rouleau, G. A., the S2D Team, Daignault, K., Diallo, O., Duguay, J., Drits, M., Henrion, E., Jolivet, P., Kuku, F., Lachapelle, K., Laliberté, G., Laurent, S., Liao, M., Marino, C., Piton, A., Raymond, A., Reynolds, A., Rochefort, D., St-Onge, J., Thibodeau, P., Tsurudome, K., Yang, Y., Leroy, S., Ossian, K., Chayet, M., & Gourion, D.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Université de Montréal (CA)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD 20892-1600;
- National Institute of Mental Health (US)
- Harvard University (US)
- Centre Hospitalier Sainte-Anne (FR)
- Douglas Mental Health University Institute (CA)
- McGill University (CA)
- Inserm (FR)
- Montreal Heart Institute (CA)
- North Carolina State University (US)
- Montreal Neurological Institute and Hospital (CA)
- Montreal General Hospital (CA)
- ORCID
- Xiong, Lan
- Spiegelman, Dan
- Hamdan, Fadi F.
- DeLisi, Lynn E.
- Krebs, Marie-Odile
- Joober, Ridha
- Mouaffak, Fayçal
- Haghighi, Ali P.
- Néri, Christian
- Dubé, Marie-Pierre
- Samuels, Mark E.
- Stone, Eric A.
- Awadalla, Philip
- Barker, Philip A.
- Drapeau, Pierre
- Rouleau, Guy A.
- Jolivet, Philippe
- Liao, Meijiang
- Piton, Amélie
- Rochefort, Daniel
- Leroy, Sophie
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-04-12
- Volume
- 107
- Issue
- 17
- Pages
- 7863-7868
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2867875
- OpenAlex
- W1978075999
- Cited by
- 369
- References
- 41
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 19 · 2023: 20 · 2022: 9 · 2021: 19 · 2020: 21 · 2019: 17 · 2018: 25 · 2017: 24 · 2016: 22 · 2015: 38 · 2014: 22 · 2013: 29 · 2012: 40
- FWCI
- 22.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Genome Canada
- Génome Québec
- Université de Montréal
- Fondation Pierre Deniker pour la Recherche et la Prévention en Santé Mentale
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- schizophrenia, SHANK3, de novo mutations, germline mosaicism, synaptic scaffolding proteins, neurodevelopmental disorders, autism spectrum disorder, hippocampal neurons, zebrafish, rats, behavioral defects, neuronal differentiation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Carrier Proteins, Female, Humans, Male, Molecular Sequence Data, Nerve Tissue Proteins, Neurons, Pedigree, Schizophrenia, Zebrafish, Sequence Analysis, DNA, DNA Primers, Microsatellite Repeats, Computational Biology, Mutation, Missense, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.